- TRADE NAME: Primacor (Sanofi-Aventis)
- INDICATIONS: Severe congestive heart failure unresponsive to conventional maintenance therapy; acute heart failure, including low output states following cardiac surgery.
- CLASS: Phosphodiesterase inhibitor
- HALF-LIFE: 2.3 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Anagrelide
Please login to view the rest of this drug profile.
Page last updated 08/20/2025
